Table of Content

1 Aurora Kinase B Antibody Market Overview
1.1 Product Overview and Scope of Aurora Kinase B Antibody
1.2 Aurora Kinase B Antibody Segment by Type
1.2.1 Global Aurora Kinase B Antibody Market Value Comparison by Type (2024-2034)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Aurora Kinase B Antibody Segment by Application
1.3.1 Global Aurora Kinase B Antibody Market Value by Application: (2024-2034)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Global Aurora Kinase B Antibody Market Size Estimates and Forecasts
1.4.1 Global Aurora Kinase B Antibody Revenue 2018-2029
1.4.2 Global Aurora Kinase B Antibody Sales 2018-2029
1.4.3 Global Aurora Kinase B Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Aurora Kinase B Antibody Market Competition by Manufacturers
2.1 Global Aurora Kinase B Antibody Sales Market Share by Manufacturers (2018-2024)
2.2 Global Aurora Kinase B Antibody Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Aurora Kinase B Antibody Average Price by Manufacturers (2018-2024)
2.4 Global Aurora Kinase B Antibody Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Aurora Kinase B Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aurora Kinase B Antibody, Product Type & Application
2.7 Aurora Kinase B Antibody Market Competitive Situation and Trends
2.7.1 Aurora Kinase B Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aurora Kinase B Antibody Players Market Share by Revenue
2.7.3 Global Aurora Kinase B Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aurora Kinase B Antibody Retrospective Market Scenario by Region
3.1 Global Aurora Kinase B Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aurora Kinase B Antibody Global Aurora Kinase B Antibody Sales by Region: 2018-2029
3.2.1 Global Aurora Kinase B Antibody Sales by Region: 2018-2024
3.2.2 Global Aurora Kinase B Antibody Sales by Region: 2024-2029
3.3 Global Aurora Kinase B Antibody Global Aurora Kinase B Antibody Revenue by Region: 2018-2029
3.3.1 Global Aurora Kinase B Antibody Revenue by Region: 2018-2024
3.3.2 Global Aurora Kinase B Antibody Revenue by Region: 2024-2029
3.4 North America Aurora Kinase B Antibody Market Facts & Figures by Country
3.4.1 North America Aurora Kinase B Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Aurora Kinase B Antibody Sales by Country (2018-2029)
3.4.3 North America Aurora Kinase B Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aurora Kinase B Antibody Market Facts & Figures by Country
3.5.1 Europe Aurora Kinase B Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Aurora Kinase B Antibody Sales by Country (2018-2029)
3.5.3 Europe Aurora Kinase B Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aurora Kinase B Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Aurora Kinase B Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Aurora Kinase B Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific Aurora Kinase B Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Aurora Kinase B Antibody Market Facts & Figures by Country
3.7.1 Latin America Aurora Kinase B Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Aurora Kinase B Antibody Sales by Country (2018-2029)
3.7.3 Latin America Aurora Kinase B Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aurora Kinase B Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Aurora Kinase B Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Aurora Kinase B Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa Aurora Kinase B Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aurora Kinase B Antibody Sales by Type (2018-2029)
4.1.1 Global Aurora Kinase B Antibody Sales by Type (2018-2024)
4.1.2 Global Aurora Kinase B Antibody Sales by Type (2024-2029)
4.1.3 Global Aurora Kinase B Antibody Sales Market Share by Type (2018-2029)
4.2 Global Aurora Kinase B Antibody Revenue by Type (2018-2029)
4.2.1 Global Aurora Kinase B Antibody Revenue by Type (2018-2024)
4.2.2 Global Aurora Kinase B Antibody Revenue by Type (2024-2029)
4.2.3 Global Aurora Kinase B Antibody Revenue Market Share by Type (2018-2029)
4.3 Global Aurora Kinase B Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global Aurora Kinase B Antibody Sales by Application (2018-2029)
5.1.1 Global Aurora Kinase B Antibody Sales by Application (2018-2024)
5.1.2 Global Aurora Kinase B Antibody Sales by Application (2024-2029)
5.1.3 Global Aurora Kinase B Antibody Sales Market Share by Application (2018-2029)
5.2 Global Aurora Kinase B Antibody Revenue by Application (2018-2029)
5.2.1 Global Aurora Kinase B Antibody Revenue by Application (2018-2024)
5.2.2 Global Aurora Kinase B Antibody Revenue by Application (2024-2029)
5.2.3 Global Aurora Kinase B Antibody Revenue Market Share by Application (2018-2029)
5.3 Global Aurora Kinase B Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sino Biological, Inc. Aurora Kinase B Antibody Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 Thermo Fisher Scientific (China) Co., Ltd.
6.2.1 Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
6.2.2 Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
6.2.3 Thermo Fisher Scientific (China) Co., Ltd. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Thermo Fisher Scientific (China) Co., Ltd. Aurora Kinase B Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Merck Aurora Kinase B Antibody Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 LifeSpan BioSciences, Inc
6.4.1 LifeSpan BioSciences, Inc Corporation Information
6.4.2 LifeSpan BioSciences, Inc Description and Business Overview
6.4.3 LifeSpan BioSciences, Inc Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.4.4 LifeSpan BioSciences, Inc Aurora Kinase B Antibody Product Portfolio
6.4.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.5 Abbexa
6.5.1 Abbexa Corporation Information
6.5.2 Abbexa Description and Business Overview
6.5.3 Abbexa Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Abbexa Aurora Kinase B Antibody Product Portfolio
6.5.5 Abbexa Recent Developments/Updates
6.6 OriGene Technologies, Inc.
6.6.1 OriGene Technologies, Inc. Corporation Information
6.6.2 OriGene Technologies, Inc. Description and Business Overview
6.6.3 OriGene Technologies, Inc. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.6.4 OriGene Technologies, Inc. Aurora Kinase B Antibody Product Portfolio
6.6.5 OriGene Technologies, Inc. Recent Developments/Updates
6.7 Biomatik
6.6.1 Biomatik Corporation Information
6.6.2 Biomatik Description and Business Overview
6.6.3 Biomatik Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Biomatik Aurora Kinase B Antibody Product Portfolio
6.7.5 Biomatik Recent Developments/Updates
6.8 MyBiosource, Inc.
6.8.1 MyBiosource, Inc. Corporation Information
6.8.2 MyBiosource, Inc. Description and Business Overview
6.8.3 MyBiosource, Inc. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.8.4 MyBiosource, Inc. Aurora Kinase B Antibody Product Portfolio
6.8.5 MyBiosource, Inc. Recent Developments/Updates
6.9 RayBiotech, Inc.
6.9.1 RayBiotech, Inc. Corporation Information
6.9.2 RayBiotech, Inc. Description and Business Overview
6.9.3 RayBiotech, Inc. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.9.4 RayBiotech, Inc. Aurora Kinase B Antibody Product Portfolio
6.9.5 RayBiotech, Inc. Recent Developments/Updates
6.10 Cell Signaling Technology, Inc.
6.10.1 Cell Signaling Technology, Inc. Corporation Information
6.10.2 Cell Signaling Technology, Inc. Description and Business Overview
6.10.3 Cell Signaling Technology, Inc. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Cell Signaling Technology, Inc. Aurora Kinase B Antibody Product Portfolio
6.10.5 Cell Signaling Technology, Inc. Recent Developments/Updates
6.11 Bio-Techne
6.11.1 Bio-Techne Corporation Information
6.11.2 Bio-Techne Aurora Kinase B Antibody Description and Business Overview
6.11.3 Bio-Techne Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Bio-Techne Aurora Kinase B Antibody Product Portfolio
6.11.5 Bio-Techne Recent Developments/Updates
6.12 Abnova
6.12.1 Abnova Corporation Information
6.12.2 Abnova Aurora Kinase B Antibody Description and Business Overview
6.12.3 Abnova Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Abnova Aurora Kinase B Antibody Product Portfolio
6.12.5 Abnova Recent Developments/Updates
6.13 CUSABIO
6.13.1 CUSABIO Corporation Information
6.13.2 CUSABIO Aurora Kinase B Antibody Description and Business Overview
6.13.3 CUSABIO Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.13.4 CUSABIO Aurora Kinase B Antibody Product Portfolio
6.13.5 CUSABIO Recent Developments/Updates
6.14 Assay Genie
6.14.1 Assay Genie Corporation Information
6.14.2 Assay Genie Aurora Kinase B Antibody Description and Business Overview
6.14.3 Assay Genie Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Assay Genie Aurora Kinase B Antibody Product Portfolio
6.14.5 Assay Genie Recent Developments/Updates
6.15 Arigo Biolaboratories Corp.
6.15.1 Arigo Biolaboratories Corp. Corporation Information
6.15.2 Arigo Biolaboratories Corp. Aurora Kinase B Antibody Description and Business Overview
6.15.3 Arigo Biolaboratories Corp. Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Arigo Biolaboratories Corp. Aurora Kinase B Antibody Product Portfolio
6.15.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.16 Biorbyt
6.16.1 Biorbyt Corporation Information
6.16.2 Biorbyt Aurora Kinase B Antibody Description and Business Overview
6.16.3 Biorbyt Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Biorbyt Aurora Kinase B Antibody Product Portfolio
6.16.5 Biorbyt Recent Developments/Updates
6.17 Creative Biolabs
6.17.1 Creative Biolabs Corporation Information
6.17.2 Creative Biolabs Aurora Kinase B Antibody Description and Business Overview
6.17.3 Creative Biolabs Aurora Kinase B Antibody Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Creative Biolabs Aurora Kinase B Antibody Product Portfolio
6.17.5 Creative Biolabs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aurora Kinase B Antibody Industry Chain Analysis
7.2 Aurora Kinase B Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aurora Kinase B Antibody Production Mode & Process
7.4 Aurora Kinase B Antibody Sales and Marketing
7.4.1 Aurora Kinase B Antibody Sales Channels
7.4.2 Aurora Kinase B Antibody Distributors
7.5 Aurora Kinase B Antibody Customers
8 Aurora Kinase B Antibody Market Dynamics
8.1 Aurora Kinase B Antibody Industry Trends
8.2 Aurora Kinase B Antibody Market Drivers
8.3 Aurora Kinase B Antibody Market Challenges
8.4 Aurora Kinase B Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Aurora Kinase B Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Aurora Kinase B Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Aurora Kinase B Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global Aurora Kinase B Antibody Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Aurora Kinase B Antibody Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Aurora Kinase B Antibody Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Aurora Kinase B Antibody Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Aurora Kinase B Antibody Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Aurora Kinase B Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Aurora Kinase B Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aurora Kinase B Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Aurora Kinase B Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aurora Kinase B Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aurora Kinase B Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aurora Kinase B Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Aurora Kinase B Antibody Sales by Region (2018-2024) & (K Units)
Table 18. Global Aurora Kinase B Antibody Sales Market Share by Region (2018-2024)
Table 19. Global Aurora Kinase B Antibody Sales by Region (2024-2029) & (K Units)
Table 20. Global Aurora Kinase B Antibody Sales Market Share by Region (2024-2029)
Table 21. Global Aurora Kinase B Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Aurora Kinase B Antibody Revenue Market Share by Region (2018-2024)
Table 23. Global Aurora Kinase B Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Aurora Kinase B Antibody Revenue Market Share by Region (2024-2029)
Table 25. North America Aurora Kinase B Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Aurora Kinase B Antibody Sales by Country (2018-2024) & (K Units)
Table 27. North America Aurora Kinase B Antibody Sales by Country (2024-2029) & (K Units)
Table 28. North America Aurora Kinase B Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Aurora Kinase B Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Aurora Kinase B Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Aurora Kinase B Antibody Sales by Country (2018-2024) & (K Units)
Table 32. Europe Aurora Kinase B Antibody Sales by Country (2024-2029) & (K Units)
Table 33. Europe Aurora Kinase B Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Aurora Kinase B Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Aurora Kinase B Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Aurora Kinase B Antibody Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Aurora Kinase B Antibody Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Aurora Kinase B Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Aurora Kinase B Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Aurora Kinase B Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Aurora Kinase B Antibody Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Aurora Kinase B Antibody Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Aurora Kinase B Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Aurora Kinase B Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Aurora Kinase B Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Aurora Kinase B Antibody Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Aurora Kinase B Antibody Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Aurora Kinase B Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Aurora Kinase B Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Aurora Kinase B Antibody Sales (K Units) by Type (2018-2024)
Table 51. Global Aurora Kinase B Antibody Sales (K Units) by Type (2024-2029)
Table 52. Global Aurora Kinase B Antibody Sales Market Share by Type (2018-2024)
Table 53. Global Aurora Kinase B Antibody Sales Market Share by Type (2024-2029)
Table 54. Global Aurora Kinase B Antibody Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Aurora Kinase B Antibody Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Aurora Kinase B Antibody Revenue Market Share by Type (2018-2024)
Table 57. Global Aurora Kinase B Antibody Revenue Market Share by Type (2024-2029)
Table 58. Global Aurora Kinase B Antibody Price (US$/Unit) by Type (2018-2024)
Table 59. Global Aurora Kinase B Antibody Price (US$/Unit) by Type (2024-2029)
Table 60. Global Aurora Kinase B Antibody Sales (K Units) by Application (2018-2024)
Table 61. Global Aurora Kinase B Antibody Sales (K Units) by Application (2024-2029)
Table 62. Global Aurora Kinase B Antibody Sales Market Share by Application (2018-2024)
Table 63. Global Aurora Kinase B Antibody Sales Market Share by Application (2024-2029)
Table 64. Global Aurora Kinase B Antibody Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Aurora Kinase B Antibody Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Aurora Kinase B Antibody Revenue Market Share by Application (2018-2024)
Table 67. Global Aurora Kinase B Antibody Revenue Market Share by Application (2024-2029)
Table 68. Global Aurora Kinase B Antibody Price (US$/Unit) by Application (2018-2024)
Table 69. Global Aurora Kinase B Antibody Price (US$/Unit) by Application (2024-2029)
Table 70. Sino Biological, Inc. Corporation Information
Table 71. Sino Biological, Inc. Description and Business Overview
Table 72. Sino Biological, Inc. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sino Biological, Inc. Aurora Kinase B Antibody Product
Table 74. Sino Biological, Inc. Recent Developments/Updates
Table 75. Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
Table 76. Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
Table 77. Thermo Fisher Scientific (China) Co., Ltd. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Thermo Fisher Scientific (China) Co., Ltd. Aurora Kinase B Antibody Product
Table 79. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Merck Aurora Kinase B Antibody Product
Table 84. Merck Recent Developments/Updates
Table 85. LifeSpan BioSciences, Inc Corporation Information
Table 86. LifeSpan BioSciences, Inc Description and Business Overview
Table 87. LifeSpan BioSciences, Inc Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. LifeSpan BioSciences, Inc Aurora Kinase B Antibody Product
Table 89. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 90. Abbexa Corporation Information
Table 91. Abbexa Description and Business Overview
Table 92. Abbexa Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Abbexa Aurora Kinase B Antibody Product
Table 94. Abbexa Recent Developments/Updates
Table 95. OriGene Technologies, Inc. Corporation Information
Table 96. OriGene Technologies, Inc. Description and Business Overview
Table 97. OriGene Technologies, Inc. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. OriGene Technologies, Inc. Aurora Kinase B Antibody Product
Table 99. OriGene Technologies, Inc. Recent Developments/Updates
Table 100. Biomatik Corporation Information
Table 101. Biomatik Description and Business Overview
Table 102. Biomatik Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Biomatik Aurora Kinase B Antibody Product
Table 104. Biomatik Recent Developments/Updates
Table 105. MyBiosource, Inc. Corporation Information
Table 106. MyBiosource, Inc. Description and Business Overview
Table 107. MyBiosource, Inc. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. MyBiosource, Inc. Aurora Kinase B Antibody Product
Table 109. MyBiosource, Inc. Recent Developments/Updates
Table 110. RayBiotech, Inc. Corporation Information
Table 111. RayBiotech, Inc. Description and Business Overview
Table 112. RayBiotech, Inc. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. RayBiotech, Inc. Aurora Kinase B Antibody Product
Table 114. RayBiotech, Inc. Recent Developments/Updates
Table 115. Cell Signaling Technology, Inc. Corporation Information
Table 116. Cell Signaling Technology, Inc. Description and Business Overview
Table 117. Cell Signaling Technology, Inc. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Cell Signaling Technology, Inc. Aurora Kinase B Antibody Product
Table 119. Cell Signaling Technology, Inc. Recent Developments/Updates
Table 120. Bio-Techne Corporation Information
Table 121. Bio-Techne Description and Business Overview
Table 122. Bio-Techne Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Bio-Techne Aurora Kinase B Antibody Product
Table 124. Bio-Techne Recent Developments/Updates
Table 125. Abnova Corporation Information
Table 126. Abnova Description and Business Overview
Table 127. Abnova Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Abnova Aurora Kinase B Antibody Product
Table 129. Abnova Recent Developments/Updates
Table 130. CUSABIO Corporation Information
Table 131. CUSABIO Description and Business Overview
Table 132. CUSABIO Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. CUSABIO Aurora Kinase B Antibody Product
Table 134. CUSABIO Recent Developments/Updates
Table 135. Assay Genie Corporation Information
Table 136. Assay Genie Description and Business Overview
Table 137. Assay Genie Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Assay Genie Aurora Kinase B Antibody Product
Table 139. Assay Genie Recent Developments/Updates
Table 140. Arigo Biolaboratories Corp. Corporation Information
Table 141. Arigo Biolaboratories Corp. Description and Business Overview
Table 142. Arigo Biolaboratories Corp. Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Arigo Biolaboratories Corp. Aurora Kinase B Antibody Product
Table 144. Arigo Biolaboratories Corp. Recent Developments/Updates
Table 145. Biorbyt Corporation Information
Table 146. Biorbyt Description and Business Overview
Table 147. Biorbyt Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Biorbyt Aurora Kinase B Antibody Product
Table 149. Biorbyt Recent Developments/Updates
Table 150. Creative Biolabs Corporation Information
Table 151. Creative Biolabs Description and Business Overview
Table 152. Creative Biolabs Aurora Kinase B Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Creative Biolabs Aurora Kinase B Antibody Product
Table 154. Creative Biolabs Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Aurora Kinase B Antibody Distributors List
Table 158. Aurora Kinase B Antibody Customers List
Table 159. Aurora Kinase B Antibody Market Trends
Table 160. Aurora Kinase B Antibody Market Drivers
Table 161. Aurora Kinase B Antibody Market Challenges
Table 162. Aurora Kinase B Antibody Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aurora Kinase B Antibody
Figure 2. Global Aurora Kinase B Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Aurora Kinase B Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global Aurora Kinase B Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Aurora Kinase B Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. Global Aurora Kinase B Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Aurora Kinase B Antibody Market Size (2018-2029) & (US$ Million)
Figure 16. Global Aurora Kinase B Antibody Sales (2018-2029) & (K Units)
Figure 17. Global Aurora Kinase B Antibody Average Price (US$/Unit) & (2018-2029)
Figure 18. Aurora Kinase B Antibody Report Years Considered
Figure 19. Aurora Kinase B Antibody Sales Share by Manufacturers in 2022
Figure 20. Global Aurora Kinase B Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Aurora Kinase B Antibody Players: Market Share by Revenue in 2022
Figure 22. Aurora Kinase B Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Aurora Kinase B Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Aurora Kinase B Antibody Sales Market Share by Country (2018-2029)
Figure 25. North America Aurora Kinase B Antibody Revenue Market Share by Country (2018-2029)
Figure 26. United States Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Aurora Kinase B Antibody Sales Market Share by Country (2018-2029)
Figure 29. Europe Aurora Kinase B Antibody Revenue Market Share by Country (2018-2029)
Figure 30. Germany Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Aurora Kinase B Antibody Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Aurora Kinase B Antibody Revenue Market Share by Region (2018-2029)
Figure 37. China Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Aurora Kinase B Antibody Sales Market Share by Country (2018-2029)
Figure 45. Latin America Aurora Kinase B Antibody Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Aurora Kinase B Antibody Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Aurora Kinase B Antibody Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Aurora Kinase B Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Aurora Kinase B Antibody by Type (2018-2029)
Figure 55. Global Revenue Market Share of Aurora Kinase B Antibody by Type (2018-2029)
Figure 56. Global Aurora Kinase B Antibody Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Aurora Kinase B Antibody by Application (2018-2029)
Figure 58. Global Revenue Market Share of Aurora Kinase B Antibody by Application (2018-2029)
Figure 59. Global Aurora Kinase B Antibody Price (US$/Unit) by Application (2018-2029)
Figure 60. Aurora Kinase B Antibody Value Chain
Figure 61. Aurora Kinase B Antibody Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed